Latest News and Press Releases

LONDON, 19 Jan. 2022 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...

INFORMATION RÉGLEMENTÉE Poursuite active du recrutement pour l’essai de Phase IIb évaluant ALLOB dans les fractures du tibia. Présentation des données principales au premier trimestre 2023,...

REGULATED INFORMATION Recruitment for ALLOB tibial facture Phase IIb study ongoing and on schedule to release topline data in Q1 2023, despite COVID slowdown New scientific advisory...

ASML reports €18.6 billion net sales and €5.9 billion net income in 2021Sales growth of around 20% expected for 2022 VELDHOVEN, the Netherlands, January 19, 2022 – today ASML Holding NV (ASML)...

Deuxième essai de phase III positif pour Dupixent® (dupilumab) dans le traitement du prurigo nodulaire, avec des améliorations significatives pour les patients Dupixent est le premier et le seul...

Second positive Phase 3 Dupixent® (dupilumab) trial confirms significant improvements for patients with prurigo nodularis Dupixent is the first and only medicine to demonstrate positive Phase 3...

Total Company Current Average Production of Approximately 30,000 BOPDAchieved 2021 Total Company Average Production of 26,500 BOPD, In-Line with GuidancePaid Down Credit Facility to $67.5 Million as...

Hampiðjan hf. hefur gert samning við Arion banka hf. um viðskiptavakt á hlutabréfum útgefnum af félaginu sem eru til viðskipta á First North Iceland markaði Kauphallar Íslands NASDAQ OMX Iceland....

Orphazyme A/SCompany announcementNo. 01/2022Inside information       Company Registration No. 32266355 Net revenue range narrowed to DKK 35 – 37 millionOperating expenses lowered to DKK 665 – 675...

Mechelen, België; 18 januari 2022; 22.01 CET; Galapagos NV (Euronext & Nasdaq: GLPG) maakt vandaag bekend dat het Medicines and Healthcare products Regulatory Agency (MHRA) de handelsvergunning...